ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
The product will be manufactured at Lupin’s facility in Goa, India.
The product will be manufactured at Lupin's facility in Nagpur, India.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Subscribe To Our Newsletter & Stay Updated
